The LMNA Gene Mandibuloacral Dysplasia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the LMNA gene that are responsible for mandibuloacral dysplasia (MAD). Mandibuloacral dysplasia is a rare genetic disorder characterized by skeletal abnormalities, skin atrophy, and a variety of systemic symptoms. The LMNA gene plays a crucial role in the structural integrity and function of the cell nucleus, and mutations in this gene can lead to a range of genetic disorders, including MAD.
This test is critical for individuals who exhibit symptoms of mandibuloacral dysplasia or have a family history of the condition, as it can provide definitive genetic evidence of the disorder. The genetic test involves analyzing the patient's DNA to detect mutations in the LMNA gene that are known to cause MAD. Early diagnosis through genetic testing can assist in the management of symptoms and in making informed decisions regarding treatment options.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The testing process is conducted in a state-of-the-art laboratory setting by skilled geneticists and technicians who ensure accurate and reliable results. The cost of the test includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings.
Patients considering the LMNA Gene Mandibuloacral Dysplasia Genetic Test are advised to consult with a genetic counselor or healthcare provider to discuss the potential benefits, limitations, and implications of the test results for themselves and their family members.
The EFTUD2 gene mandibulofacial dysostosis with microcephaly genetic test is a specialized diagnostic procedure offered at DNA Labs UAE. This test specifically targets the EFTUD2 gene, mutations in which are known to cause mandibulofacial dysostosis with microcephaly, a rare genetic disorder. This condition is characterized by distinctive facial features, microcephaly (a smaller than normal head size), and often intellectual disabilities among other symptoms.
The test is designed to identify mutations in the EFTUD2 gene, providing crucial information for the diagnosis, management, and understanding of the condition for affected individuals and their families. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic testing techniques.
The cost of the EFTUD2 gene mandibulofacial dysostosis with microcephaly genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to pinpoint the specific mutation within the EFTUD2 gene that may be causing the condition. Knowing the genetic basis of the disorder can help in planning the appropriate medical care, support, and genetic counseling for families, providing them with vital information about the condition's inheritance pattern and implications for future pregnancies.
DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experts in genetic analysis, ensuring high-quality testing and reliable results for patients seeking answers about this rare genetic disorder.
The PIEZO2 gene Marden-Walker Syndrome genetic test is a sophisticated diagnostic tool designed to identify mutations in the PIEZO2 gene, which are associated with Marden-Walker Syndrome. This rare genetic disorder is characterized by multiple congenital contractures, including camptodactyly (permanent flexion of the fingers), blepharophimosis (narrowing of the eye openings), and mask-like facial features, among other symptoms. The condition is inherited in an autosomal recessive manner, meaning that both copies of the gene in each cell have mutations for the disorder to manifest.
The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed to detect any abnormalities in the PIEZO2 gene. This genetic test is crucial for accurate diagnosis, enabling targeted interventions and management strategies for individuals with Marden-Walker Syndrome.
The cost of the PIEZO2 gene Marden-Walker Syndrome genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to specialized care and support for affected individuals and their families.
The FBN1 Gene Marfan Lipodystrophy Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are associated with Marfan Syndrome and a form of lipodystrophy. Marfan Syndrome is a genetic disorder affecting the body's connective tissue, leading to symptoms in the heart, eyes, blood vessels, and skeleton. Lipodystrophy associated with mutations in the FBN1 gene is a rare condition characterized by the abnormal distribution of fat in the body. This genetic test is crucial for individuals showing symptoms of these conditions or those with a family history, as it can provide definitive answers regarding their genetic status.
The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the FBN1 gene. This information is vital for the early diagnosis and management of the conditions, allowing for personalized treatment plans and preventive measures to mitigate the risks associated with the disorders.
The cost of the FBN1 Gene Marfan Lipodystrophy Syndrome Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the valuable insights it offers into the patient's genetic health, it represents a significant step forward in the management and understanding of these genetic conditions.
The FBN1 gene Marfan Syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the FBN1 gene, which are closely associated with Marfan Syndrome. Marfan Syndrome is a genetic disorder that affects the body's connective tissue, leading to abnormalities in the heart, blood vessels, bones, joints, and eyes. The FBN1 gene plays a critical role in the production of fibrillin-1, a protein essential for the formation of elastic fibers found in connective tissue.
Conducted at DNA Labs UAE, this test is crucial for individuals with a family history of Marfan Syndrome or those showing symptoms of the condition. Early detection through this genetic test allows for timely management and treatment plans to mitigate the risk of complications such as aortic dissection and vision problems.
The cost of the FBN1 gene Marfan Syndrome genetic test at DNA Labs UAE is 4400 AED. This investment in health provides valuable insights into an individual's genetic predisposition to Marfan Syndrome, enabling proactive measures for those affected and their families.
The RAB3GAP2 gene plays a crucial role in the development and function of various systems in the body. Mutations in this gene are associated with Martsolf syndrome, a rare genetic disorder characterized by intellectual disability, cataracts, hypogonadism, and other physical abnormalities. To diagnose this condition, genetic testing of the RAB3GAP2 gene is essential.
DNA Labs UAE offers a specialized genetic test for Martsolf syndrome by analyzing the RAB3GAP2 gene. This test is crucial for confirming the diagnosis, understanding the severity of the condition, and guiding treatment and management decisions. The test is performed using a sample of the patient's blood or saliva, employing advanced genetic sequencing technologies to detect mutations in the RAB3GAP2 gene.
The cost of the RAB3GAP2 gene test for Martsolf syndrome at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic analysis, and a comprehensive report that explains the results. The report is invaluable for healthcare providers in planning the best course of action for patients with Martsolf syndrome and for families to understand the genetic basis of the condition.
The FBN1 Gene MASS Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are associated with MASS syndrome. MASS syndrome is a connective tissue disorder that shares some clinical features with Marfan syndrome, including abnormalities in the skeletal, ocular, and cardiovascular systems, but without the aortic enlargement seen in Marfan syndrome. The test involves analyzing the patient's DNA to detect any genetic variations in the FBN1 gene that might indicate the presence of MASS syndrome.
This genetic testing is crucial for early diagnosis and management of the syndrome, allowing for personalized treatment plans and monitoring for potential complications. The cost of the FBN1 Gene MASS Syndrome Genetic Test at DNA Labs UAE is 4400 AED, reflecting the comprehensive nature of this genetic analysis and the specialized expertise required to interpret the results. Conducted in a state-of-the-art facility, this test is a valuable tool for individuals with a family history of MASS syndrome or related symptoms, offering them crucial insights into their genetic health.
The XK Gene McLeod Syndrome with or without Chronic Granulomatous Disease Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect genetic mutations associated with McLeod Syndrome and Chronic Granulomatous Disease. McLeod Syndrome is a rare condition characterized by various symptoms, including neuromuscular and hematological abnormalities, often linked to the XK gene mutation. Chronic Granulomatous Disease (CGD) is an immune disorder that results from defects in the immune system's ability to kill certain bacteria and fungi, leading to recurrent infections and granuloma formation. This genetic test aims to identify individuals carrying mutations that could lead to either or both conditions, facilitating early diagnosis and management.
The test is priced at 4400 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed to ensure accurate results. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test involves collecting a DNA sample from the patient, usually through a blood draw. The genetic material is then analyzed for specific mutations in the XK gene and other related genes that could indicate a predisposition to McLeod Syndrome or Chronic Granulomatous Disease.
By identifying these genetic mutations, healthcare providers can offer personalized treatment plans, preventive measures, and counseling for affected individuals and their families. This proactive approach aims to improve the quality of life for those with these rare conditions and to better understand the genetic underpinnings that contribute to their development.
The PIK3R2 gene megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome genetic test is a specialized diagnostic tool designed to identify mutations in the PIK3R2 gene, which are associated with the development of a complex neurological condition. This syndrome is characterized by an abnormally large brain (megalencephaly), excessive folding of the brain's surface (polymicrogyria), the presence of extra fingers or toes (polydactyly), and an accumulation of fluid in the brain (hydrocephalus). The test is critical for early diagnosis and management of the condition, enabling healthcare providers to tailor interventions and support to the needs of the affected individual.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis, which includes detailed genetic sequencing and interpretation by specialists in the field. This test is particularly valuable for families with a history of the syndrome or related symptoms, offering a vital resource for understanding genetic risk and planning for the health needs of their children.
The AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the AKT3 gene, which are associated with the development of the syndrome. This condition is characterized by abnormal brain development, leading to an enlarged brain (megalencephaly), excessive folds in the brain's surface (polymicrogyria), the presence of extra fingers or toes (polydactyly), and the accumulation of excess cerebrospinal fluid in the brain (hydrocephalus).
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test involves analyzing the patient's DNA to detect mutations in the AKT3 gene, which plays a crucial role in brain development and function. By identifying these mutations, healthcare providers can confirm the diagnosis of Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2, enabling them to tailor treatment and management strategies to the specific needs of the patient. This genetic testing is a vital tool for families seeking answers to complex neurological conditions, offering insights that can guide medical care and support.
